Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30652Source: DataRank Database

Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumors is a research paper published in Pediatric Blood & Cancer (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.00)OA: bronzeTopics (35)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Kevin X. Liu ORCID,A. Lindsay Frazier ORCID,Allison F. O’Neill ORCID,Katherine A. Janeway ORCID,Steven G. DuBois ORCID

Live enrichment

PubMed:37644664 PMC:PMC10528491 OpenAlex:https://openalex.org/W4386271786

NCI NIH HHS

Grant: L40 CA264321

Rally Foundation

FWCI

0.00

Citation Percentile

0.2%

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pbc.30652

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pbc.30652

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30652

journalhttps://doi.org/10.1002/pbc.30652

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37644664

Fields of Study

Chronic Myeloid Leukemia TreatmentsCAR-T cell therapy researchSarcoma Diagnosis and TreatmentHumansChildTyrosine Kinase InhibitorsRetrospective StudiesPrevalenceProtein Kinase InhibitorsSarcomaLung Neoplasms

MeSH Terms

Tyrosine Kinase InhibitorsChildHumansLung NeoplasmsRetrospective StudiesSarcomaPrevalenceProtein Kinase Inhibitors

Keywords

MedicineInternal medicineCohortRetrospective cohort studyDosingSarcomaToxicityCancerTyrosine-kinase inhibitorCohort studyOncologyGastroenterologySurgeryPathologyTyrosine kinase inhibitorSolid tumor

Sustainable Development Goals

SDG 0: Good health and well-being